143 related articles for article (PubMed ID: 26406948)
21. High expression of nucleobindin 2 is associated with poor prognosis in gastric cancer.
Altan B; Kaira K; Okada S; Saito T; Yamada E; Bao H; Bao P; Takahashi K; Yokobori T; Tetsunari O; Nishiyama M; Yamada M
Tumour Biol; 2017 Jul; 39(7):1010428317703817. PubMed ID: 28714371
[TBL] [Abstract][Full Text] [Related]
22. Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer.
Su Y; Lin L; Zhang J; Jiang Y; Pan C; Sun L; Duan J; Liao W
Mol Med Rep; 2015 Oct; 12(4):5771-9. PubMed ID: 26239822
[TBL] [Abstract][Full Text] [Related]
23. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia induces the expression of transketolase-like 1 in human colorectal cancer.
Bentz S; Cee A; Endlicher E; Wojtal KA; Naami A; Pesch T; Lang S; Schubert P; Fried M; Weber A; Coy JF; Goelder S; Knüchel R; Hausmann M; Rogler G
Digestion; 2013; 88(3):182-92. PubMed ID: 24193262
[TBL] [Abstract][Full Text] [Related]
25. Expression of DBC1 and SIRT1 is associated with poor prognosis of gastric carcinoma.
Cha EJ; Noh SJ; Kwon KS; Kim CY; Park BH; Park HS; Lee H; Chung MJ; Kang MJ; Lee DG; Moon WS; Jang KY
Clin Cancer Res; 2009 Jul; 15(13):4453-9. PubMed ID: 19509139
[TBL] [Abstract][Full Text] [Related]
26. Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted.
Langbein S; Zerilli M; Zur Hausen A; Staiger W; Rensch-Boschert K; Lukan N; Popa J; Ternullo MP; Steidler A; Weiss C; Grobholz R; Willeke F; Alken P; Stassi G; Schubert P; Coy JF
Br J Cancer; 2006 Feb; 94(4):578-85. PubMed ID: 16465194
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis.
Wang CY; Hua L; Yao KH; Chen JT; Zhang JJ; Hu JH
Int J Clin Exp Pathol; 2015; 8(1):779-85. PubMed ID: 25755774
[TBL] [Abstract][Full Text] [Related]
28. Association between the expression of T-cadherin and vascular endothelial growth factor and the prognosis of patients with gastric cancer.
Wei B; Shi H; Lu X; Shi A; Cheng Y; Dong L
Mol Med Rep; 2015 Aug; 12(2):2075-81. PubMed ID: 25847144
[TBL] [Abstract][Full Text] [Related]
29. Loss of ARID1A expression is associated with poor prognosis in patients with gastric cancer.
Zhu YP; Sheng LL; Wu J; Yang M; Cheng XF; Wu NN; Ye XB; Cai J; Wang L; Shen Q; Wu JQ
Hum Pathol; 2018 Aug; 78():28-35. PubMed ID: 29689245
[TBL] [Abstract][Full Text] [Related]
30. GLUT-1(+)/TKTL1(+) coexpression predicts poor outcome in oral squamous cell carcinoma.
Grimm M; Munz A; Teriete P; Nadtotschi T; Reinert S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jun; 117(6):743-53. PubMed ID: 24703406
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer.
Inoue T; Iinuma H; Ogawa E; Inaba T; Fukushima R
Oncol Rep; 2012 Jun; 27(6):1759-64. PubMed ID: 22407237
[TBL] [Abstract][Full Text] [Related]
32. GRIK3: A novel oncogenic protein related to tumor TNM stage, lymph node metastasis, and poor prognosis of GC.
Gong B; Li Y; Cheng Z; Wang P; Luo L; Huang H; Duan S; Liu F
Tumour Biol; 2017 Jun; 39(6):1010428317704364. PubMed ID: 28631555
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of tumor suppressor QKI in gastric cancer and its implication in cancer prognosis.
Bian Y; Wang L; Lu H; Yang G; Zhang Z; Fu H; Lu X; Wei M; Sun J; Zhao Q; Dong G; Lu Z
Biochem Biophys Res Commun; 2012 May; 422(1):187-93. PubMed ID: 22569043
[TBL] [Abstract][Full Text] [Related]
34. A biomarker based detection and characterization of carcinomas exploiting two fundamental biophysical mechanisms in mammalian cells.
Grimm M; Schmitt S; Teriete P; Biegner T; Stenzl A; Hennenlotter J; Muhs HJ; Munz A; Nadtotschi T; König K; Sänger J; Feyen O; Hofmann H; Reinert S; Coy JF
BMC Cancer; 2013 Dec; 13():569. PubMed ID: 24304513
[TBL] [Abstract][Full Text] [Related]
35. [Expression and significance of RhoA and NF-ΚB in human gastric carcinoma].
Su XJ; Tang ZF; Li Q; Li HL; Li LL; Liu M; Zhou YN
Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):276-9. PubMed ID: 21575498
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer.
Yang Q; Zhang C; Huang B; Li H; Zhang R; Huang Y; Wang J
Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):953-7. PubMed ID: 23751352
[TBL] [Abstract][Full Text] [Related]
37. The lymphangiogenic factor SOX 18: a key indicator to stage gastric tumor progression.
Eom BW; Jo MJ; Kook MC; Ryu KW; Choi IJ; Nam BH; Kim YW; Lee JH
Int J Cancer; 2012 Jul; 131(1):41-8. PubMed ID: 21796627
[TBL] [Abstract][Full Text] [Related]
38. NEDD9 overexpression correlates with poor prognosis in gastric cancer.
Liu Y; Wang D; Zhao KL; Zhu JW; Yin HB; Wei YZ; Wu ZJ; Cheng GJ; Wang F; Ni F; Wang XL; Cao GX; Huang J; Cai J
Tumour Biol; 2014 Jul; 35(7):6351-6. PubMed ID: 24664584
[TBL] [Abstract][Full Text] [Related]
39. AKR1B10, a good prognostic indicator in gastric cancer.
Yao HB; Xu Y; Chen LG; Guan TP; Ma YY; He XJ; Xia YJ; Tao HQ; Shao QS
Eur J Surg Oncol; 2014 Mar; 40(3):318-24. PubMed ID: 24406159
[TBL] [Abstract][Full Text] [Related]
40. Decreased expression of T-cadherin is associated with gastric cancer prognosis.
Tang Y; Dai Y; Huo J
Hepatogastroenterology; 2012 Jun; 59(116):1294-8. PubMed ID: 22414547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
